These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 15197227)

  • 1. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes.
    Boulé MW; Broughton C; Mackay F; Akira S; Marshak-Rothstein A; Rifkin IR
    J Exp Med; 2004 Jun; 199(12):1631-40. PubMed ID: 15197227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
    Leadbetter EA; Rifkin IR; Hohlbaum AM; Beaudette BC; Shlomchik MJ; Marshak-Rothstein A
    Nature; 2002 Apr; 416(6881):603-7. PubMed ID: 11948342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinucleosome autoantibodies bind directly to cell lines in vitro and via the FcgammaRIIB receptor to B lymphocytes in vivo: a role for immune complexes in interactions between antinucleosome IgG2a and B cells of BXSB lupus mice.
    Li X; Egorina E; Bertelsen EL; Dahlen H; Hannestad K
    Scand J Immunol; 2004; 60(1-2):121-33. PubMed ID: 15238081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism.
    Säemann MD; Weichhart T; Zeyda M; Staffler G; Schunn M; Stuhlmeier KM; Sobanov Y; Stulnig TM; Akira S; von Gabain A; von Ahsen U; Hörl WH; Zlabinger GJ
    J Clin Invest; 2005 Feb; 115(2):468-75. PubMed ID: 15650774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.
    Yu P; Wellmann U; Kunder S; Quintanilla-Martinez L; Jennen L; Dear N; Amann K; Bauer S; Winkler TH; Wagner H
    Int Immunol; 2006 Aug; 18(8):1211-9. PubMed ID: 16798839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
    Christensen SR; Shupe J; Nickerson K; Kashgarian M; Flavell RA; Shlomchik MJ
    Immunity; 2006 Sep; 25(3):417-28. PubMed ID: 16973389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting mechanisms of interferon-α inhibition by intravenous immunoglobulin after induction by immune complexes versus Toll-like receptor agonists.
    Wiedeman AE; Santer DM; Yan W; Miescher S; Käsermann F; Elkon KB
    Arthritis Rheum; 2013 Oct; 65(10):2713-23. PubMed ID: 23840006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
    Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
    J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging roles of TLR7 and TLR9 in murine SLE.
    Santiago-Raber ML; Baudino L; Izui S
    J Autoimmun; 2009; 33(3-4):231-8. PubMed ID: 19846276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.
    Barrat FJ; Meeker T; Gregorio J; Chan JH; Uematsu S; Akira S; Chang B; Duramad O; Coffman RL
    J Exp Med; 2005 Oct; 202(8):1131-9. PubMed ID: 16230478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
    Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
    Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential activation of dendritic cells by Toll-like receptor agonists isolated from the Gram-positive vaccine vector Streptococcus gordonii.
    Mayer ML; Phillips CM; Townsend RA; Halperin SA; Lee SF
    Scand J Immunol; 2009 Apr; 69(4):351-6. PubMed ID: 19284500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
    Brummel R; Roberts TL; Stacey KJ; Lenert P
    Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune complex enhances tolerogenecity of immature dendritic cells via FcγRIIb and promotes FcγRIIb-overexpressing dendritic cells to attenuate lupus.
    Zhang Y; Liu S; Yu Y; Zhang T; Liu J; Shen Q; Cao X
    Eur J Immunol; 2011 Apr; 41(4):1154-64. PubMed ID: 21360699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-CpG-containing antisense 2'-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 88.
    Senn JJ; Burel S; Henry SP
    J Pharmacol Exp Ther; 2005 Sep; 314(3):972-9. PubMed ID: 15919763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRF-7 is the master regulator of type-I interferon-dependent immune responses.
    Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T
    Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.
    Lövgren T; Eloranta ML; Kastner B; Wahren-Herlenius M; Alm GV; Rönnblom L
    Arthritis Rheum; 2006 Jun; 54(6):1917-27. PubMed ID: 16729300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus.
    Means TK; Luster AD
    Ann N Y Acad Sci; 2005 Dec; 1062():242-51. PubMed ID: 16461805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection.
    Guiducci C; Vicari AP; Sangaletti S; Trinchieri G; Colombo MP
    Cancer Res; 2005 Apr; 65(8):3437-46. PubMed ID: 15833879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic BM-DC activation and immune induction by the oral vaccine vector Streptococcus gordonii and exogenous tumor necrosis factor.
    Mayer ML; Phillips CM; Stadnyk AW; Halperin SA; Lee SF
    Mol Immunol; 2009 May; 46(8-9):1883-91. PubMed ID: 19278729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.